Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
China Pharmacy
1001-0408
2012 Issue 18
xin xing kang gao xue ya yao a li ji lun de xin shen bao hu zuo yong yan jiu jin zhan
fang shao hua lin ying peng zuo zuo juan hu min
..............page:1704-1706
Determination of Repaglinide Concentration in Human Plasma and Bioequivalent Study of Its Tablets by LC-MS
REN Jin-min;SUN Qian;YIN Li-xin;WANG Chuan-ping;ZHANG Zhi-qing;WANG Shu-mei
..............page:1668-1670
Effect Evaluation of Application of Clinical Pathway in Pediatric Surgery
HE Jian-hua;ZHU Wei-chao;WANG Lei-bo;XU Ke-tao;YUAN Li-jun
..............page:1650-1652
Analysis of Status Quo of Clinical Pathway in “Paid by Disease Types” in China
FENG Shuai;SHI Lu-wen SHI Lu-wen
..............page:1633-1635
Simultaneous Determination of Paracetamol and Amantadine in Human Plasma and Bioequivalence of Its Preparations in Healthy Volunteers by LC-MS
XIAO Xue;ZHANG Dan;ZHAO Ting;YANG Man;QIANG Gui-fen;ZHANG Ya-nan;LIU Hui-chen
..............page:1671-1673
Clinical Pharmacists and Rational Drug Use under Clinical Pathway Management Mode
PANG Jia-lian;MENG Guang-yi;TANG Hua-bin
..............page:1641-1644
Analysis of Drug Use in a Patient with Craniocerebral Trauma Complicating with Epilepsy by Clinical Pharmacist
LIN Yu-xian;XIONG Jian-hua;ZHOU Shu-hua;CHEN Yuan-yuan
..............page:1721-1723
Influencing Factors of Subject Compliance of Anti-cancer Drug Clinical Trial and Pharmaceutical Intervention
KOU Ying-ying;TANG Yi-qun KOU Ying-ying;WU Jian-qiu;ZHANG Yan;LI Mei;FENG Ji-feng
..............page:1711-1713
Design of a Revolutionary Pricing Method of Medical Service by Disease Types in China
FENG Shuai;SHI Lu-wen SHI Lu-wen
..............page:1635-1638
Determination of Azithromycin Concentration in Human Plasma by UPLC-MS
SHEN Guo-rong;DONG Ji;MIAO Li-yan
..............page:1665-1668
Application of Markov Model in the Calculation of Utility Value of Pharmacoeconomics and Case Study
WANG Si-ying;PENG Liu-bao;ZENG Xiao-hui;OUYANG Li-hui WANG Si-ying;PENG Liu-bao;ZENG Xiao-hui;OUYANG Li-hui
..............page:1653-1656
Case Analysis of Clinical Pharmacists Participating in the Consultation for a Patient with Pulmonary Tuberculosis Complicating with Hypothyriodism
CAO Guo-wen;CAO Bin;SHI Ai-ming;SHEN Zhu;YANG Wen-bin;ZHANG Quan-ying
..............page:1723-1725
Analysis of 769 Adverse Drug Reaction Reports in Our Hospital
SUN Jia-yue
..............page:1702-1704
Application Value of Carbon Nanoparticles in Radical Resection for Colonic Carcinoma
HUANG Jiong-qiang;LEI Jian;CHEN Jing-song;CHEN Yuan-guang;HU Ming;KE Chuan-feng
..............page:1698-1700
Foreign DRGs Pricing Flow and Its Enlightenment to “Pricing by Disease Types” in China
FENG Shuai;SHI Lu-wen SHI Lu-wen
..............page:1638-1641
Understanding of Clinical Pharmacist to the Blood Lipid in the Early Period of Acute Coronary Syndrome
LI Qin;XI Yu-fei;LI Xiao-yu;LIU Gao-lin DAI Jian-wei
..............page:1719-1720
Experience of Hospital Pharmacists Participating in Clinical Pathway
MENG Li;TANG Jing;SUN Deng-kun;GUO Hong;LIU Qun;QI Xiao-lian
..............page:1644-1645
Intervention Study on Perioperative Prophylactic Application of Antibiotics in Type Ⅰ Incision Surgery in 19 Hospitals from Jinmen Area
LIAO Qiu-xia;LIU Chen-hui;LI Yang-hua;LI Chang-hai;SHAO Yin;HU Yao-mei ZHANG Song-bai XIAO Guang-xiong
..............page:1656-1658
chang wai ying yang ye zhong jia ru -3 yu you zhi fang ru zhu she ye de lin chuang ying yong
xiong de qiao du biao guo hua ting
..............page:1709-1710
Application of Clinical Nursing Pathway in 63 Patients with Community-required Pneumonia
YE Mian-zhi;ZHU Xiu-zhen;CHEN Chong;DENG Zai-chun
..............page:1648-1650
Effects of Tirofiban on the Plasma Soluble OX40L in Patients with ACS after PCI Treatment
CHEN Zhi-gang;HUAN Lu-li;YUE Bing;ZHANG Yong-chun
..............page:1693-1695
Study on Compatible Stability of Cefmetazole Sodium for Injection Mixed with 2 Kinds of Drugs
CHEN Yao;LIU Qing-qing;XIAO Yu-ting
..............page:1679-1681